The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III TRIDENT trial: Radiation and temozolomide +/- tumor treating fields in newly diagnosed glioblastoma.
 
Wenyin Shi
Consulting or Advisory Role - Brainlab; Novocure; Varian Medical Systems
Research Funding - BrainLAB (Inst); Novocure (Inst); Regeneron (Inst)
 
Lawrence Kleinberg
Consulting or Advisory Role - Novocure
Research Funding - Arbor Pharmaceuticals (Inst); Novocure (Inst)
 
Suriya A. Jeyapalan
Consulting or Advisory Role - Novocure
 
Samuel Aaron Goldlust
Stock and Other Ownership Interests - COTA
Honoraria - Bristol-Myers Squibb; Novocure; Tocagen; Wex Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Cortice Biosciences; Novocure; Tocagen; Wex Pharmaceuticals
Speakers' Bureau - Novocure
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Amgen (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Cantex Pharmaceuticals (Inst); Celgene (Inst); Celldex (Inst); CNS Healthcare (Inst); Cortice Biosciences (Inst); Diffusion Pharmaceuticals (Inst); ImmunoCellular Therapeutics (Inst); Karyopharm Therapeutics (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Novogen (Inst); Tocagen (Inst); Wex Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Boston Biomedical; Novocure; Tocagen; Wex Pharmaceuticals
 
Seema Nagpal
Consulting or Advisory Role - Abbvie; GW Pharmaceuticals; Kiyatec; Novocure; Tocagen
Research Funding - Berg Pharma; Inovio Pharmaceuticals; Regeneron (Inst); tocagen (Inst)
Travel, Accommodations, Expenses - Abbvie; Novocure; Tocagen
 
David A. Reardon
Honoraria - Advantagene; Agenus; Bayer; Bristol-Myers Squibb; DelMar Pharmaceuticals; EMD Serono; Imvax; Merck; Merck KGaA; Novartis; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical
Consulting or Advisory Role - Advantagene; Agenus; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; EMD Serono; Imvax; Merck; Merck KGaA; Novartis; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Incyte (Inst); Omniox
 
Stephanie E Combs
No Relationships to Disclose
 
David Roberge
Stock and Other Ownership Interests - Arctic Fox AI; Croton Healthcare
Consulting or Advisory Role - Novocure
Research Funding - Bristol-Myers Squibb (Inst); Elekta (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - IntraOp; Siemens Healthineers
 
Ryo Nishigawa
Consulting or Advisory Role - Novocure
 
Martin Glas
Honoraria - Bayer; Kyowo Kirin; Medac; Merck; Novartis; Novocure
Consulting or Advisory Role - Abbvie; Daiichi Sankyo; Novartis; Novocure; Roche
Travel, Accommodations, Expenses - Medac; Novocure